Related Experiment Videos
Abstract:
Twenty patients undergoing urgent or emergency surgical procedures where intra-abdominal infection was suspected were treated with doxycycline hyclate. Wound infections involving anaerobic, aerobic, or facultative bacteria developed in four of 11 patients treated with doxycycline alone. Nine other patients received higher doses of doxycycline plus gentamicin sulfate. Five of these had postoperative infections primarily involving anaerobic organisms. Bacteremia with a doxycycline-resistant Bacteroides fragilis developed in one patient during therapy. Serum levels of doxycycline, even at the higher dosage, were below the minimal inhibitory concentrations (MICs) of a number of potential pathogens isolated at the time of surgery. Doxycycline is not indicated in cases of serious intra-abdominal infection unless the infecting flora are known to be susceptible.
Insights
Doxycycline hyclate monotherapy is not recommended for serious intra-abdominal infections due to low serum levels and treatment failures. Alternative antibiotics are necessary when bacterial susceptibility is unknown.
Area of Science:
- Infectious Diseases
- Pharmacology
- Surgical Infections
Background:
- Intra-abdominal infections pose significant clinical challenges, often requiring prompt antibiotic intervention.
- Urgent and emergency surgical procedures increase the risk of severe bacterial infections.
- Evaluating antibiotic efficacy in complex surgical settings is crucial for patient outcomes.
Observation:
- Twenty patients with suspected intra-abdominal infections received doxycycline hyclate.
- Four of 11 patients on doxycycline alone developed wound infections.
- Nine patients receiving higher-dose doxycycline plus gentamicin sulfate also experienced postoperative infections.
Findings:
- Serum doxycycline levels were frequently below minimal inhibitory concentrations (MICs) for isolated pathogens.
- Postoperative infections occurred even with combination therapy, involving anaerobic organisms.
- Bacteremia with doxycycline-resistant Bacteroides fragilis was observed during treatment.
Implications:
- Doxycycline hyclate monotherapy is insufficient for treating serious intra-abdominal infections.
- Empirical use of doxycycline should be avoided unless pathogen susceptibility is confirmed.
- Gentamicin combination therapy did not fully overcome doxycycline's limitations in this cohort.